What is the mechanism of action of Tofacitinib (Xeljanz)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: September 19, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

In a patient with synovial chondromatosis and early hip osteoarthritis on tofacitinib 5 mg daily who needs hip arthroscopy in 3 months but cannot stop the JAK inhibitor due to severe groin/hip stiffness, what alternative peri‑operative management can be used until surgery?

What are the dosing regimens, monitoring requirements, contraindications, and alternative therapies for oral tofacitinib in adults with moderate to severe ulcerative colitis, rheumatoid arthritis, or psoriatic arthritis?

In a 27‑year‑old man with hip synovial chondromatosis diagnosed 4 years ago and early osteoarthritis on ultrasound, who has been taking tofacitinib 5 mg daily with occasional severe stiffness, should the tofacitinib be continued?

How should I manage a patient with hip synovial chondromatosis and early‑onset osteoarthritis (≈4 years), currently taking tofacitinib 5 mg daily (a JAK inhibitor) and a cartilage‑degenerative supplement, who continues to have significant hip stiffness?

What precautions and monitoring are necessary when initiating tofacitinib (Janus kinase inhibitor) therapy?

What is the target temperature range for post cardiac arrest patients?

What is the role of markers such as EGFR (Epidermal Growth Factor Receptor) mutations, ALK (Anaplastic Lymphoma Kinase) rearrangements, and PD-L1 (Programmed Death-Ligand 1) expression in guiding treatment strategies for lung neoplasms?

What is the recommended dosage and usage of Trazodone (antidepressant) for treating major depressive disorder and insomnia?

What is the management approach for a patient with Chronic Obstructive Pulmonary Disease (COPD) experiencing hemoptysis?

What is the management of hemoptysis in a patient on anticoagulants (blood thinners)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.